According to a study published today by the journal European Addiction Research, medical cannabis can help reduce opioid use while improving sleep, anxiety, and overall quality of life in patients with substance use disorder (SUD). For the study, researchers analyzed data from 34 patients enrolled in the UK Medical Cannabis Registry, most of whom had …
Study: 90% of CBD Hemp Biomass Becomes Waste, But Anaerobic Digestion Offers a Cleaner Solution
A new study published in Resources, Conservation and Recycling evaluates the environmental impacts of various end-of-life treatments for hemp biomass generated during cannabidiol (CBD) production—and finds anaerobic digestion (AD) offers the most sustainable waste disposal option. CBD extraction leaves behind roughly 90% of the hemp plant as waste, much of which is incinerated, composted, or …
Omaha Tribe of Nebraska to Begin Legal Cannabis Sales to Everyone 21+, Including Non-Tribal Members, in Early 2026
The Omaha Tribe of Nebraska is set to become the first jurisdiction in the state to launch legal cannabis sales for both medical patients and all adults 21 and older—including non-Tribal members—starting in 2026. The plan follows the Tribal Council’s unanimous adoption of Title 51, a comprehensive Cannabis Regulatory Code that establishes a fully legal …
Texas Senate Passes Bill to Ban Hemp THC
The Texas Senate has passed Senate Bill 5, a proposal that would ban hemp-derived THC products and impose strict regulations on CBD and CBG. The Senate approved the bill today through its second reading, with a third and final reading expected on Friday. Once advanced through the third reading, the proposal will be sent to …
Clinical Trial: Topical CBD Gel Reduces Migraines and Improves Sleep in People With Bruxism-Related Muscle Pain
A new clinical trial conducted by researchers at the Medical University of Silesia in Katowice found that topical cannabidiol (CBD) gel significantly improved sleep quality and reduced migraine-related disability in individuals suffering from bruxism-associated muscle pain. The randomized, double-blind study involved 60 participants divided into three groups: one received a placebo, while the others received …
Study: Cannabis Use Not Linked to Kidney Function Decline or Chronic Kidney Disease
A new study conducted by researchers at Johns Hopkins University School of Medicine and the National Institutes of Health found no independent link between cannabis use and negative kidney health outcomes over time. The study, published in Cannabis and Cannabinoid Research, analyzed data from over 1,500 adults in Baltimore, Maryland. Participants were enrolled in the …
Texas Senators File Bill to Legalize Marijuana Statewide
A group of lawmakers in the Texas Senate has introduced new legislation that would legalize marijuana for adults and establish a regulated commercial industry. Filed today as Senate Bill 54, the proposal is sponsored by Senators Nathan Johnson, Carol Alvarado, Molly Cook, Roland Gutierrez, Jose Menendez, and Borris Miles, all Democrats. The measure covers a …
Massachusetts Regulators Approve Draft Rules for Marijuana Cafes, Set Stage for Public Hearings
Massachusetts regulators have unanimously approved draft rules that would allow for marijuana to be consumed in designated social settings, clearing a major hurdle in the state’s long-awaited push to launch cannabis cafes. The Cannabis Control Commission voted today to send the proposed rules to Secretary of the Commonwealth Bill Galvin, triggering the start of a …
Study: U.S. Physicians Unprepared to Guide Patients on Medical Marijuana Due to Knowledge Gaps and Inconsistent Training
A comprehensive review published in the peer-reviewed journal Medical Cannabis and Cannabinoids has found that physicians across the United States often feel ill-equipped to recommend or discuss medical marijuana (MC) with patients, largely due to limited education and training, inconsistent clinical guidelines, and federal-state legal conflicts. Researchers at the NYIT College of Osteopathic Medicine conducted …
Report: Cannabis-Infused Products Market Valued at $33 Billion in 2025, Expected to Reach $78.5 Billion by 2029
The global market for cannabis-infused products is expected to surge from $33.85 billion in 2025 to $78.51 billion by 2029, growing at a compound annual growth rate of 23.4%, according to a new report by Research and Markets. The report attributes the sector’s rapid expansion to continued marijuana legalization, rising consumer interest in wellness-focused products, …













